STOCKWATCH
·
Biotechnology: Pharmaceutical Preparations
AcquisitionsMar 30, 2026, 03:35 AM

Abbott to Acquire Exact Sciences for $105 per Share in Cash

AI Summary

Abbott Laboratories has entered into a definitive agreement to acquire Exact Sciences Corporation for $105.00 per share in cash. The merger will result in Exact Sciences becoming a wholly-owned subsidiary of Abbott, expanding Abbott's diagnostics portfolio.

Key Highlights

  • Abbott will acquire Exact Sciences for $105.00 per share in cash.
  • Exact Sciences will become a wholly-owned subsidiary of Abbott.
  • The merger is subject to customary closing conditions, including shareholder approval and regulatory approvals.
ABT
Biotechnology: Pharmaceutical Preparations
ABBOTT LABORATORIES

Price Impact